Paul Tudor Jones Insmed Inc Call Options Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
Call Options
2 transactions
Others Institutions Holding INSM
# of Institutions
489Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.21 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.02 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$947 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$858 Million0.12% of portfolio
-
Capital International Investors Los Angeles, CA7.2MShares$478 Million0.11% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $8.99B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...